Clinical Trial Update: Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2) [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 trial comparing atorvastatin and rosuvastatin for preventing contrast-induced acute kidney injury in acute coronar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Acute Kidney Injury
• Coronary Syndrome

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Lipitor (atorvastatin)

Snippet

Sponsor: Centro Cardiopatici Toscani | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED